The use of CRISPR/Cas9 technology in the study of chronic lymphocytic leukemia

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	PESCHELOVÁ Helena KOZLOVÁ Veronika HEJRET Václav ŠMÍDA Michal
Year of publication	2019
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Description	CRISPR/Cas9-mediated gene knockout of TP53 and ATM in HG3 cell line: models for chronic lymphocytic leukemia, CRISPR/Cas9-mediated gene knockout of TP53 and ATM in HG3 cell line: models for chronic lymphocytic leukemia.
Related projects:	CEITEC 2020